Frontiers in Medicine | Hepatobiliary Diseases

Original Research

Published on 28 Mar 2025

Construction and evaluation of a diagnostic model for metabolic dysfunction-associated steatotic liver disease based on advanced glycation end products and their receptors

in Hepatobiliary Diseases

Xiao Cao
Xiaohua Xiao
Peipei Jiang
Nian Fu

Frontiers in Medicine

doi 10.3389/fmed.2025.1539708

167 views

Original Research

Published on 28 Mar 2025

Exploring the severity and risk factors of non-alcoholic fatty liver disease using the SAF scoring system

in Hepatobiliary Diseases

Xinxin Li
Shiyu Wang
Ziyu Zhang
Wen Deng
Yaqin Zhang
Weihua Cao
Xin Wei
Zixuan Gao
Linmei Yao
Shuojie Wang

Frontiers in Medicine

doi 10.3389/fmed.2025.1510679

118 views

Original Research

Accepted on 27 Mar 2025

Periodontal Diseases, Potential Mediators and Development of Liver Fat Content: a Community-Based Large Cohort

in Hepatobiliary Diseases

Bofu Liu
Yu Jia
GU Zhihan
Yizhou Li
Zhou Yiheng
Yu Cao

Frontiers in Medicine

doi 10.3389/fmed.2025.1563459

Case Report

Accepted on 27 Mar 2025

Common Bile Duct Exploration with Choledochotomy and Primary Repair during Pregnancy: Case Report

in Hepatobiliary Diseases

Jiaqi Chen
Liyong Zhang
Wenjuan Zhang
Zejin Zhao
Aijun Yu
Jian Li
Zhuqing Zhang
Kai Chen

Frontiers in Medicine

doi 10.3389/fmed.2025.1559568

Original Research

Accepted on 27 Mar 2025

Bacteroides fragilis 839 ameliorates anti-tuberculosis drugs-induced liver injury by suppressing inflammation and regulating gut microbiota in mice

in Hepatobiliary Diseases

Qiujuan Li
Chenbing Wu
Kangshuai Zhang
Ziyi Zhou
Jing Li
Jie Bai
Jun Cao
Xiaoxia Shi

Frontiers in Medicine

doi 10.3389/fmed.2025.1538528

Editorial

Published on 27 Mar 2025

Editorial: Lipid metabolism in metabolic dysfunction- associated steatotic liver disease

in Hepatobiliary Diseases

Sheetalnath Rooge
Nirajan Shrestha

Frontiers in Medicine

doi 10.3389/fmed.2025.1584932

153 views

Editorial

Published on 27 Mar 2025

Editorial: Advances in chemotherapy-resistant hepatocellular carcinoma, volume II

in Hepatobiliary Diseases

Shui Liu
Yufan Liu
Mo Sha
Yang Li
Jiyao Sheng

Frontiers in Medicine

doi 10.3389/fmed.2025.1594854

125 views

Review

Published on 26 Mar 2025

Ferroptosis in NAFLD: insights and the therapeutic potential of exercise

in Hepatobiliary Diseases

Chang Li
Dongkun Deng
Qingfeng Jiang
Jiaming Shi
Lin Xu
Yufei Liu

Frontiers in Medicine

doi 10.3389/fmed.2025.1462145

100 views

Clinical Trial

Published on 25 Mar 2025

Effectiveness and risks of dapagliflozin in treatment for metabolic dysfunction-associated steatotic liver disease with type 2 diabetes: a randomized controlled trial

in Hepatobiliary Diseases

Hiroo Fukada
Kazuyoshi Kon
Reiko Yaginuma
Akira Uchiyama
Maki Morinaga
Kei Ishizuka
Kyoko Fukuhara
Hironao Okubo
Satoko Suzuki
Shuko Nojiri

Frontiers in Medicine

doi 10.3389/fmed.2025.1542741

246 views

Original Research

Accepted on 24 Mar 2025

Diagnostic and Prognostic Biomarkers in Autoimmune Hepatitis-Associated Cirrhosis: Insights into TBil, CD38, IL-22,TSP-1, GAL-3, and Cyc-C

in Hepatobiliary Diseases

Jiani Shi
Jingbo Fu
Caijie He
Jun Shen

Frontiers in Medicine

doi 10.3389/fmed.2025.1564107

Original Research

Accepted on 24 Mar 2025

The association of advanced lung cancer inflammation index with nonalcoholic fatty liver disease in NHANES 2017-2020

in Hepatobiliary Diseases

Lin Cheng
Shumeng Li
Hui Li
Jiafeng You
Mingwei Yu
Guowang Yang

Frontiers in Medicine

doi 10.3389/fmed.2025.1516464

Original Research

Published on 24 Mar 2025

The gamma-glutamyl transpeptidase to platelet ratio: a good noninvasive biomarker for predicting for the occurrence and prognosis of patients with hepatitis E virus-related acute liver failure

in Hepatobiliary Diseases

Shuai Zhu
Jun Yuan
Feng Ju
Mengmeng Gu
Ze Xiang
Yan Zhang

Frontiers in Medicine

doi 10.3389/fmed.2025.1573114

194 views

Case Report

Published on 24 Mar 2025

Inflammatory myofibroblastic tumor in the liver after bone marrow transplantation: case report and literature review

in Hepatobiliary Diseases

Shuhui Yang
Yongsheng Tang
Zenan Yuan
Jianwen Zhang

Frontiers in Medicine

doi 10.3389/fmed.2025.1489399

183 views

Original Research

Accepted on 20 Mar 2025

Plasma methylated HIST1H3G as a non-invasive biomarker for diagnostic modeling of hepatocellular carcinoma

in Hepatobiliary Diseases

Weiwei Zhu
Huifen Wang
Yudie Cai
Jun Lei
Jia Yu
Li Ang
Zujiang Yu

Frontiers in Medicine

doi 10.3389/fmed.2025.1571737

Case Report

Published on 19 Mar 2025

Case Report: Cholecystitis and gastric perforation caused by a fishbone and treated by laparoscopic surgery

in Hepatobiliary Diseases

Xuemin Li
Junfeng Cheng
Yonghang Wang
Zhijun Chen
Zewei Chen
Chao Ren

Frontiers in Medicine

doi 10.3389/fmed.2025.1523249

228 views

Review

Published on 17 Mar 2025

Cracking the code of HBV persistence: cutting-edge approaches to targeting cccDNA in chronic hepatitis B with or without pyogenic liver Abscesses

in Hepatobiliary Diseases

Umar Saeed
Zahra Zahid Piracha
Mahmood Khan
Muhammad Nouman Tariq
Syed Shayan Gilani
Muhammad Raza
Rakshana Munusamy
Naveen Bose
Dilber Uzun Ozsahin
İlker Özşahin

Frontiers in Medicine

doi 10.3389/fmed.2025.1504736

439 views

Navigation group

Articles

Construction and evaluation of a diagnostic model for metabolic dysfunction-associated steatotic liver disease based on advanced glycation end products and their receptors

Exploring the severity and risk factors of non-alcoholic fatty liver disease using the SAF scoring system

Periodontal Diseases, Potential Mediators and Development of Liver Fat Content: a Community-Based Large Cohort

Common Bile Duct Exploration with Choledochotomy and Primary Repair during Pregnancy: Case Report

Bacteroides fragilis 839 ameliorates anti-tuberculosis drugs-induced liver injury by suppressing inflammation and regulating gut microbiota in mice

Editorial: Lipid metabolism in metabolic dysfunction- associated steatotic liver disease

Editorial: Advances in chemotherapy-resistant hepatocellular carcinoma, volume II

Ferroptosis in NAFLD: insights and the therapeutic potential of exercise

Effectiveness and risks of dapagliflozin in treatment for metabolic dysfunction-associated steatotic liver disease with type 2 diabetes: a randomized controlled trial

Diagnostic and Prognostic Biomarkers in Autoimmune Hepatitis-Associated Cirrhosis: Insights into TBil, CD38, IL-22,TSP-1, GAL-3, and Cyc-C

The association of advanced lung cancer inflammation index with nonalcoholic fatty liver disease in NHANES 2017-2020

The gamma-glutamyl transpeptidase to platelet ratio: a good noninvasive biomarker for predicting for the occurrence and prognosis of patients with hepatitis E virus-related acute liver failure

Inflammatory myofibroblastic tumor in the liver after bone marrow transplantation: case report and literature review

Plasma methylated HIST1H3G as a non-invasive biomarker for diagnostic modeling of hepatocellular carcinoma

Case Report: Cholecystitis and gastric perforation caused by a fishbone and treated by laparoscopic surgery

Cracking the code of HBV persistence: cutting-edge approaches to targeting cccDNA in chronic hepatitis B with or without pyogenic liver Abscesses